SBI Contra Fund Direct Growth NAV Verified at ₹396.0702 on 7 October 2026

Key Takeaways

• SBI Contra Fund Direct Growth’s NAV was verified at ₹396.0702 for 7 October 2026 through the permitted Value Research Direct Plan Growth record.
• The 5paisa performance snapshot dated 6 October reported a one-year return of -4.54%, a three-year CAGR of 10.00% and a five-year CAGR of 13.99%.
• The available 5paisa snapshot displayed assets of ₹47,589 crore, with TREPS at 7.11% and Reliance Industries the largest listed equity entry at 4.75%.

SBI Contra Fund Direct Growth recorded a verified NAV of ₹396.0702 for 7 October 2026. Value Research’s scheme-specific Direct Plan record explicitly paired this amount with the requested date under its Growth NAV display. The four-decimal precision has been retained throughout this article. A daily percentage movement is not reported because the displayed movement could not be reconciled reliably.

During verification, the refreshed 5paisa primary card continued to show ₹398.42 for 6 October. That earlier value has not been relabelled as the requested-date NAV. The fallback applies specifically to this scheme’s exact-date valuation, rather than replacing the source hierarchy for the full article batch.

Supporting performance data is separately dated. The 5paisa table for 6 October showed -4.54% over one year, a three-year CAGR of 10.00% and a five-year CAGR of 13.99%. These figures are included as the available historical snapshot, not as verified returns calculated through 7 October. The five-year figure exceeded the three-year figure by 3.99 percentage points.

TREPS was the largest overall disclosed allocation at 7.11%, while Reliance Industries was the largest listed equity holding at 4.75%. ICICI Bank, HDFC Bank and Biocon accounted for 4.55%, 4.54% and 3.47%, respectively. The five entries, including TREPS, totalled 24.42%; the four named equities alone represented 17.31%.

The available operating snapshot displayed assets of ₹47,589 crore and a 0.88% expense ratio. Minimum SIP and lump-sum amounts were ₹500 and ₹5,000. Those fields are supporting information and have not been assigned the NAV’s valuation date without separate confirmation.

The contra classification describes a contrarian equity approach. Neither that label nor the historical return differences establish when particular holdings might reprice. The daily article records the verified unit value and identifies the dates and limits of the accompanying evidence.